Guardant Health Cl Stock Price To Sales

5GH Stock  EUR 33.99  0.36  1.07%   
GUARDANT HEALTH CL fundamentals help investors to digest information that contributes to GUARDANT HEALTH's financial success or failures. It also enables traders to predict the movement of GUARDANT Stock. The fundamental analysis module provides a way to measure GUARDANT HEALTH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GUARDANT HEALTH stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

GUARDANT HEALTH CL Company Price To Sales Analysis

GUARDANT HEALTH's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

P/S

 = 

MV Per Share

Revenue Per Share

More About Price To Sales | All Equity Analysis
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Competition

Based on the latest financial disclosure, GUARDANT HEALTH CL has a Price To Sales of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Diagnostics & Research industry. The price to sales for all Germany stocks is 100.0% higher than that of the company.

GUARDANT Price To Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GUARDANT HEALTH's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GUARDANT HEALTH could also be used in its relative valuation, which is a method of valuing GUARDANT HEALTH by comparing valuation metrics of similar companies.
GUARDANT HEALTH is currently under evaluation in price to sales category among its peers.

GUARDANT Fundamentals

About GUARDANT HEALTH Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze GUARDANT HEALTH CL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GUARDANT HEALTH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GUARDANT HEALTH CL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in GUARDANT Stock

GUARDANT HEALTH financial ratios help investors to determine whether GUARDANT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GUARDANT with respect to the benefits of owning GUARDANT HEALTH security.